Search - tctmd.com

Displaying 201 - 220 of 278

Sort: Relevancy | Date

News Daily News

RE-VERSE AD: Dabigatran Antidote Appears Safe, Effective in Interim Analysis

June 25, 2015

News Industry News

Knowledge Gaps and Misperceptions on Impact of Atrial Fibrillation and Stroke Exist Among Patients, Caregivers and Physicians

May 13, 2015

News Daily News

A-fib Identified as a Risk Factor for Incident NSTEMI

Todd Neale

May 07, 2015

Presentation

A-fib and Risk of STEMI vs NSTEMI

Presenter: Elsayed Z. Soliman

May 06, 2015

News Daily News

Silent A-fib After Acute MI Portends Poor Outcome

Yael L. Maxwell

May 01, 2015

Presentation

Prognosis of Silent A-fib After Acute MI at 1 Year

Presenter: K. Stamboul

April 30, 2015

News Daily News

High-Sensitivity Troponin Assay More Precisely Calibrates Mortality Risk in Suspected ACS Patients

April 20, 2015

News Daily News

HF Worsens Outcomes Following ACS, With No Benefit From Apixaban

Todd Neale

January 28, 2015

News Daily News

Un Estudio de Registro Analiza el Papel que juega la Fibrinólisis en Pacientes STEMI con Tiempos de Traslado Más Largos

Yael L. Maxwell

January 12, 2015

News Daily News

2014 Guideline for NSTE-ACS Management Has New Name, Focus

September 30, 2014

Presentation TCT 2014

Thoughtful Insights

Presenter: Neal S. Kleiman

September 17, 2014

Presentation TCT 2014

Case Presentation

Presenter: Frederick Kushner

September 17, 2014

News Daily News

STREAM: La Estrategia Inicial Fibrinolítica es Segura al cabo de 1 Año cuando la realización de una PCI Primaria en el Momento Adecuado es Inalcanzable

L.A. McKeown

September 11, 2014

News Daily News

STREAM: Early Fibrinolytic Strategy Safe at 1 Year When Timely Primary PCI is Unattainable

L.A. McKeown

September 11, 2014

News Daily News

HORIZONS-AMI亚组研究：直接PCI后抗凝血产生的结果更差

September 02, 2014

News Daily News

HORIZONS-AMI Substudy: Anticoagulation After Primary PCI Yields Worse Outcomes

September 02, 2014

News Conference News ESC 2014

IBIS-4: High-Dose Statin Therapy May Reverse Atherosclerosis in STEMI

Todd Neale

September 02, 2014

News Conference News ESC 2014

APOLLO: Worse Long-Term Outcomes in American vs European Survivors of Acute MI

Yael L. Maxwell

August 31, 2014

News Daily News

In-Hospital Switching of Antiplatelet Agents in MI Patients Relatively Common, Driven by Patient Risk, Other Factors

L.A. McKeown

August 20, 2014

News Daily News

El Cambio Intrahospitalario de Agentes Antiplaquetarios en Pacientes PCI es Relativamente Frecuente y está Condicionado por el Riesgo del Paciente y Otros Factores

L.A. McKeown

August 20, 2014

Advertisement

RE-VERSE AD: Dabigatran Antidote Appears Safe, Effective in Interim Analysis

Knowledge Gaps and Misperceptions on Impact of Atrial Fibrillation and Stroke Exist Among Patients, Caregivers and Physicians

A-fib Identified as a Risk Factor for Incident NSTEMI

A-fib and Risk of STEMI vs NSTEMI

Silent A-fib After Acute MI Portends Poor Outcome

Prognosis of Silent A-fib After Acute MI at 1 Year

High-Sensitivity Troponin Assay More Precisely Calibrates Mortality Risk in Suspected ACS Patients

HF Worsens Outcomes Following ACS, With No Benefit From Apixaban

Un Estudio de Registro Analiza el Papel que juega la Fibrinólisis en Pacientes STEMI con Tiempos de Traslado Más Largos

2014 Guideline for NSTE-ACS Management Has New Name, Focus

Thoughtful Insights

Case Presentation

STREAM: La Estrategia Inicial Fibrinolítica es Segura al cabo de 1 Año cuando la realización de una PCI Primaria en el Momento Adecuado es Inalcanzable

STREAM: Early Fibrinolytic Strategy Safe at 1 Year When Timely Primary PCI is Unattainable

HORIZONS-AMI亚组研究：直接PCI后抗凝血产生的结果更差

HORIZONS-AMI Substudy: Anticoagulation After Primary PCI Yields Worse Outcomes

IBIS-4: High-Dose Statin Therapy May Reverse Atherosclerosis in STEMI

APOLLO: Worse Long-Term Outcomes in American vs European Survivors of Acute MI

In-Hospital Switching of Antiplatelet Agents in MI Patients Relatively Common, Driven by Patient Risk, Other Factors

El Cambio Intrahospitalario de Agentes Antiplaquetarios en Pacientes PCI es Relativamente Frecuente y está Condicionado por el Riesgo del Paciente y Otros Factores

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content